Search Results

1 - 9 of 9 items :

  • "haemophilia" x
  • Haematology, Oncology x
Clear All
Implantoprosthetic rehabilitation of a patient with severe form of hemophilia B: a case report

subcommittee of factor VIII and factor IX of the scientific and standarization committee of the International Society on Thrombosis and Haemostasis Thromb Haemost. 2001 85 560 [4] Lehmann-Kopydlowska M, Zawilska K. Dental guidelines in congenital hemophilia A and B. Czas Stomatol. 2010;63(6):345-357. Lehmann-Kopydlowska M Zawilska K. Dental guidelines in congenital hemophilia A and B Czas Stomatol. 2010 63 6 345 357 [5] Bjorkman S, Carlsson M, Berntop E. Pharmacokinetics of factor IX in patients with haemophilia B: Methodological aspects and physiological interpretation

Open access
Progressive arthropathy in the course of immune tolerance induction failure in a child with hemophilia A and FVIII inhibitor – a case report

children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties. Haemophilia 2017;23:654–59. 28574205 10.1111/hae.13264 Collins P Chalmers E Alamelu J et al First-line immune tolerance induction for children with severe haemophilia A: a protocol from the UK Haemophilia Centre Doctors’ Organisation Inhibitor and Paediatric Working Parties Haemophilia 2017 23 654 59 [2] Ananyeva NM, Lacroix-Esmazes S, Hauser CA. Inhibitors in hemophilia A: mechanisms of inhibitor

Open access
Diagnostic accuracy of haemophilia early arthropathy detection with ultrasound (HEAD-US): a comparative magnetic resonance imaging (MRI) study

2000 42 205 9 PMID: 11105618 3 Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12: 117-21. 10.1111/j.1365-2516.2006.01268.x Roosendaal G Lafeber FP Pathogenesis of haemophilic arthropathy Haemophilia 2006 12 117 21 10.1111/j.1365-2516.2006.01268.x 4 Manco-Johnson MJ, Abshire TC, Schapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44. 10.1056/NEJMoa067659 Manco

Open access
False-negative coagulation factor activity results due to the presence of antiphospholipid antibodies in a case of autoimmune hemolytic anemia

detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 2007;13:317-322. 10.1111/j.1365-2516.2007.01450.x Sahud MA Pratt KP Zhukov O Qu K Thompson AR. ELISA system for detection of immune responses to FVIII. a study of 246 samples and correlation with the Bethesda assay Haemophilia 2007 13 317 322 [12] Tiede A, Werwitzke S, Scharf RE: Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803-811. 10.1055/s-0034-1390004 Tiede A Werwitzke S Scharf

Open access
Terapia manualna po alloplastyce stawu kolanowego u pacjenta z artropatią hemofilową w przebiegu hemofilii A – studium przypadku

arthroplasty. Haemophilia 2011;17:999–1004. Viliani T Zambelan G Pandolfi C et al In‐patient rehabilitation in haemophilic subjects with total knee arthroplasty Haemophilia 2011 17 999 1004 [4] Stephensen D, Bladen M, McLaughlin P. Recent advances in musculoskeletal physiotherapy for haemophilia. Ther Adv Hematol 2018;9:227–37. 10.1177/2040620718784834 30181843 Stephensen D Bladen M McLaughlin P Recent advances in musculoskeletal physiotherapy for haemophilia Ther Adv Hematol 2018 9 227 37 [5] Jaworski JM, Zawojski A, Zdziarska J

Open access
Overview and management of toxicities of immune checkpoint-blocking drugs

neurological toxicities have been also reported with ipilimumab, such as Guillain-Barre syndrome ( 57 ). In addition, asymptomatic laboratory elevation of amylase and lipase that does not fulfil the criteria of acute pancreatitis is a common finding, and its clinical significance is unknown ( 7 , 12 ). Red cell aplasia, neutropenia, thrombocytopenia, and acquired hemophilia A have been described in patients treated with ipilimumab ( 58 - 59 ). Discussion and future directions Treatment with ICIs has dramatically changed the landscape of advanced cancer treatment

Open access
Spinal subdural haematoma in von Willebrand disease

disease. Haemophilia 2001; 7: 592-4. Karibe H, Niizuma H, Ohyama H, Shirane R, Yoshimoto T. Hepatitis C virus (HCV) infection as a risk factor for spontaneous intracerebral hemorrhage: hospital based case-control study. J Clin Neurosci 2001; 8: 423-5. Kyriakides AE, Lalam RK, El Masry WS. Acute spontaneous spinal subdural hematoma presenting as paraplegia: a rare case. Spine 2007; 32: E619-622. Rajer M, Kovač V. Malignant spinal cord compression. Radiol Oncol 2008; 42: 23

Open access
Electrogene therapy with interleukin-12 in canine mast cell tumors

. In vivo electroporation for gene therapy. Hum Gene Ther 2006; 17 : 890-7. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3 : 574-83. Draghia-Akli R, Hahn KA, King GK, Cummings KK, Carpenter RH. Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer. Mol Ther 2002; 6 : 830

Open access
Abnormal hemostasis screening tests leading to diagnosis of multiple myeloma

typical for MM (84%). Complete blood count (CBC) abnormalities include normocytic anemia (ca 70%), rouleaux-forming erythrocytes (50%), leukopenia and thrombocytopenia (20% and 5%, respectively) [ 1 , 2 ]. It is known that plasma cell dyscrasias can be accompanied by both thrombotic and hemorrhagic events, including venous thrombosis, acquired von Willebrand syndrome and acquired hemophilia. Increased risk of venous thromboembolism in myeloma patients is associated with increased FVIII and von Willebrand factor activity [ 3 , 4 , 5 ], decreased protein S activity

Open access